Company Overview - Simulations Plus, Inc. is a global leader in model-informed and AI-accelerated drug development, focusing on enhancing biopharma innovation through advanced software and consulting solutions [4]. Event Announcement - The company will host a virtual Investor Day on January 21, 2026, providing an in-depth look at its long-term strategy, product roadmap, and financial outlook, along with a Q&A session with the executive leadership team [2][7]. Industry Context - Biopharma companies are increasingly prioritizing predictability, transparency, and scientific rigor in drug development, and Simulations Plus aims to support these needs through its unified strategy [3]. Strategic Vision - The event will showcase Simulations Plus' vision for an integrated, AI-enabled modeling ecosystem that spans discovery, development, clinical operations, and commercialization [3]. Agenda Highlights - The agenda will include updates on the industry environment, the company's unified product and technology strategy, advances in scientific services supporting client workflows, and financial priorities and outlook [7].